-
1
-
-
0035115180
-
In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci
-
DOI 10.1128/AAC.45.3.825-836.2001
-
P. Hebeisen, I. Heinze-Krauss, P. Angehrn, P. Hohl, M.G. Page, and R.L. Then In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci Antimicrob Agents Chemother 45 2001 825 836 (Pubitemid 32182033)
-
(2001)
Antimicrobial Agents and Chemotherapy
, vol.45
, Issue.3
, pp. 825-836
-
-
Hebeisen, P.1
Heinze-Krauss, I.2
Angehrn, P.3
Hohl, P.4
Page, M.G.P.5
Then, R.L.6
-
3
-
-
25844470484
-
Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin
-
DOI 10.1128/AAC.49.10.4210-4219.2005
-
T. Bogdanovich, L.M. Ednie, S. Shapiro, and P.C. Appelbaum Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin Antimicrob Agents Chemother 49 2005 4210 4219 (Pubitemid 41400966)
-
(2005)
Antimicrobial Agents and Chemotherapy
, vol.49
, Issue.10
, pp. 4210-4219
-
-
Bogdanovich, T.1
Ednie, L.M.2
Shapiro, S.3
Appelbaum, P.C.4
-
4
-
-
0842346267
-
In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria
-
DOI 10.1016/j.diagmicrobio.2003.09.006
-
N.C. Issa, M.S. Rouse, K.E. Piper, W.R. Wilson, J.M. Steckelberg, and R. Patel In vitro activity of BAL9141 against clinical isolates of Gram-negative bacteria Diagn Microbiol Infect Dis 48 2004 73 75 (Pubitemid 38167504)
-
(2004)
Diagnostic Microbiology and Infectious Disease
, vol.48
, Issue.1
, pp. 73-75
-
-
Issa, N.C.1
Rouse, M.S.2
Piper, K.E.3
Wilson, W.R.4
Steckelberg, J.M.5
Patel, R.6
-
5
-
-
73849107006
-
In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa
-
J. Fernandez, J.J. Hilliard, D. Abbanat, W. Zhang, J.L. Melton, and C.M. Santoro In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa Antimicrob Agents Chemother 54 2010 116 125
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 116-125
-
-
Fernandez, J.1
Hilliard, J.J.2
Abbanat, D.3
Zhang, W.4
Melton, J.L.5
Santoro, C.M.6
-
6
-
-
14744278669
-
Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus
-
DOI 10.1128/AAC.49.3.884-888.2005
-
H.F. Chambers Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus Antimicrob Agents Chemother 49 2005 884 888 (Pubitemid 40327700)
-
(2005)
Antimicrobial Agents and Chemotherapy
, vol.49
, Issue.3
, pp. 884-888
-
-
Chambers, H.F.1
-
7
-
-
0036136841
-
BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis
-
DOI 10.1128/AAC.46.1.171-177.2002
-
J.M. Entenza, P. Hohl, I. Heinze-Krauss, M.P. Glauser, and P. Moreillon BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis Antimicrob Agents Chemother 46 2002 171 177 (Pubitemid 34031620)
-
(2002)
Antimicrobial Agents and Chemotherapy
, vol.46
, Issue.1
, pp. 171-177
-
-
Entenza, J.M.1
Hohl, P.2
Heinze-Krauss, I.3
Glauser, M.P.4
Moreillon, P.5
-
8
-
-
70350686593
-
Ceftobiprole: A new cephalosporin for the treatment of skin and skin structure infections
-
P.L. Schirmer, and S.C. Deresinski Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections Expert Rev Anti Infect Ther 7 2009 777 791
-
(2009)
Expert Rev Anti Infect Ther
, vol.7
, pp. 777-791
-
-
Schirmer, P.L.1
Deresinski, S.C.2
-
10
-
-
79951952461
-
-
Comité de l'Antibiogramme de la Société Française de Microbiologie Paris, France: Société Française de Microbiologie [accessed4January2011]
-
Comité de l'Antibiogramme de la Société Franaise de Microbiologie. Recommandations 2010. Paris, France: Société Franaise de Microbiologie. http://www.sfm-microbiologie.org [accessed 4 January 2011].
-
Recommandations 2010
-
-
-
11
-
-
54249114022
-
-
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Basel, Switzerland: European Society of Clinical Microbiology and Infectious Diseases (ESCMID) [accessed4January2011]
-
European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical breakpoints. Basel, Switzerland: European Society of Clinical Microbiology and Infectious Diseases (ESCMID); 2009. http://www.eucast.org [accessed 4 January 2011].
-
(2009)
Clinical Breakpoints
-
-
-
12
-
-
79951948954
-
Antimicrobial susceptibility testing: Practical implementation of the EUCAST breakpoints and methods
-
10-13 April 2010, Vienna, Austria. Basel, Switzerland: European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Educational workshop 8
-
Kahlmeter G, Brown D. Antimicrobial susceptibility testing: practical implementation of the EUCAST breakpoints and methods. In: European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); 10-13 April 2010, Vienna, Austria. Basel, Switzerland: European Society of Clinical Microbiology and Infectious Diseases (ESCMID); 2010. Educational workshop 8.
-
(2010)
European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
-
-
Kahlmeter, G.1
Brown, D.2
-
13
-
-
0036924109
-
In vitro evaluation of BAL9141, a novel parental cephalosporin active against oxacillin-resistant staphylococci
-
DOI 10.1093/jac/dkf249
-
R.N. Jones, L.M. Deshpande, A.H. Mutnick, and D.J. Biedenbach In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci J Antimicrob Chemother 50 2002 915 932 (Pubitemid 36032813)
-
(2002)
Journal of Antimicrobial Chemotherapy
, vol.50
, Issue.6
, pp. 915-932
-
-
Jones, R.N.1
Deshpande, L.M.2
Mutnick, A.H.3
Biedenbach, D.J.4
-
14
-
-
40049097830
-
In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent Gram-positive and Gram-negative isolates of European origin
-
DOI 10.1093/jac/dkm492
-
C.M. Pillar, M.K. Aranza, D. Shah, and D.F. Sahm In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent Gram-positive and Gram-negative isolates of European origin J Antimicrob Chemother 61 2008 595 602 (Pubitemid 351321133)
-
(2008)
Journal of Antimicrobial Chemotherapy
, vol.61
, Issue.3
, pp. 595-602
-
-
Pillar, C.M.1
Aranza, M.K.2
Shah, D.3
Sahm, D.F.4
-
15
-
-
77957335538
-
Differential selection of single-step AmpC or efflux mutants of Pseudomonas aeruginosa using cefepime, ceftazidime, or ceftobiprole
-
A.M. Queenan, W. Shang, K. Bush, and R.K. Flamm Differential selection of single-step AmpC or efflux mutants of Pseudomonas aeruginosa using cefepime, ceftazidime, or ceftobiprole Antimicrob Agents Chemother 54 2010 4092 4097
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 4092-4097
-
-
Queenan, A.M.1
Shang, W.2
Bush, K.3
Flamm, R.K.4
|